Clinical Trials Logo

Clinical Trial Summary

Various drugs have been used for the purpose: nitroglycerine, sodium nitroprusside, propofol, beta blockers, calcium channel blockers, higher concentrations of inhalational anesthetics etc. Since all these drugs have certain limitations there was a search for more safe and effective drug


Clinical Trial Description

Functional Endoscopic Sinus Surgery (FESS) is done via endoscope and the area is highly vascular thus it becomes important to minimize bleeding, hence we require hypotensive anesthesia. Dexmedetomidine (a highly selective α2-receptor agonist that has sedative, analgesic, anxiolytic, and opioid sparing effects without significant respiratory depression) it also reduces the need for inhaled anesthetics. dexmedetomidine also minimizes postoperative opioid consumption as well as nausea, vomiting, and anxiety. Melatonin is a neurohormone mainly secreted from the pineal gland by the suprachiasmatic nucleus. It possesses a circadian secretion pattern and regulates the biological clock; it also offers antiemetic, analgesic, and anxiolytic effects. Due to its effect on both acute and chronic pain, melatonin (available in 5mg tablet form) fulfills a beneficial role in reducing postoperative opioid consumption while minimizing nausea and vomiting. Pregabalin, whose structure is similar to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), possesses analgesic and anxiolytic activities and is effective in alleviating the neuropathic component of acute nociceptive pain of surgery. It has also been used as premedication to attenuate the hemodynamic stress response to laryngoscopy and intubation and to decrease intraoperative anesthetic requirement ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05829148
Study type Interventional
Source Egymedicalpedia
Contact Tarek Mounir, Professor
Phone +201012140880
Email tarekmunir99@gmail.com
Status Not yet recruiting
Phase Early Phase 1
Start date May 1, 2023
Completion date November 20, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04078659 - Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery N/A
Not yet recruiting NCT03417206 - PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Recruiting NCT03417180 - SPI-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02692794 - Large Scale Cerebral Oximetry During Sinus Endoscopy N/A
Completed NCT05930132 - The Role of the Submucosal Conchoplasty Technique in Improving the Postoperative Middle Meatus Outcome After ESS N/A
Completed NCT03229551 - Xylitol for Chronic Sinusitis Phase 2/Phase 3
Active, not recruiting NCT04356196 - Comparative Study Between the Efficacy of Verapamil and Bisoprolol on Reduction of Bleeding During Endoscopic Sinus Surgery Under General Anaesthesia. Early Phase 1
Completed NCT03228914 - Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery Phase 4
Completed NCT03389763 - SPI-guided vs PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02182492 - Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery N/A
Recruiting NCT04852562 - The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps N/A
Recruiting NCT05145543 - Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery Phase 2/Phase 3
Completed NCT02748070 - Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP) N/A
Completed NCT01564355 - Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery N/A